Search

Your search keyword '"van Gelder, Isabelle C"' showing total 27 results
Start Over Author "van Gelder, Isabelle C" Publisher wiley
27 results on '"van Gelder, Isabelle C"'

1. Cardioversion strategy impacts rate control during recurrences in patients with paroxysmal atrial fibrillation: A subanalysis of the RACE 7 ACWAS trial

Author

van der Velden, Rachel M. J., primary, Pluymaekers, Nikki A. H. A., additional, Dudink, Elton A. M. P., additional, Luermans, Justin G. L. M., additional, Meeder, Joan G., additional, Heesen, Wilfred F., additional, Lenderink, Timo, additional, Widdershoven, Jos W. M. G., additional, Bucx, Jeroen J. J., additional, Rienstra, Michiel, additional, Kamp, Otto, additional, van Opstal, Jurren M., additional, Kirchhof, Charles J. H. J., additional, van Dijk, Vincent F., additional, Swart, Henk P., additional, Alings, Marco, additional, Van Gelder, Isabelle C., additional, Crijns, Harry J. G. M., additional, and Linz, Dominik, additional

Published
2023
Full Text
View/download PDF

2. Ventricular tachyarrhythmia detection by implantable loop recording in patients with heart failure and preserved ejection fraction: the VIP‐HF study

Author

van Veldhuisen, Dirk J., primary, van Woerden, Gijs, additional, Gorter, Thomas M., additional, van Empel, Vanessa P.M., additional, Manintveld, Olivier C., additional, Tieleman, Robert G., additional, Maass, Alexander H., additional, Vernooy, Kevin, additional, Westenbrink, B. Daan, additional, van Gelder, Isabelle C., additional, and Rienstra, Michiel, additional

Published
2020
Full Text
View/download PDF

3. Association between heart failure aetiology and magnitude of echocardiographic remodelling and outcome of cardiac resynchronization therapy

Author

Kloosterman, Mariëlle, primary, Stipdonk, Antonius M.W., additional, Horst, Iris, additional, Rienstra, Michiel, additional, Van Gelder, Isabelle C., additional, Vos, Marc A., additional, Prinzen, Frits W., additional, Meine, Matthias, additional, Vernooy, Kevin, additional, and Maass, Alexander H., additional

Published
2020
Full Text
View/download PDF

4. Genetic risk and atrial fibrillation in patients with heart failure

Author

Kloosterman, Mariëlle, primary, Santema, Bernadet T., additional, Roselli, Carolina, additional, Nelson, Christopher P., additional, Koekemoer, Andrea, additional, Romaine, Simon. P.R., additional, Van Gelder, Isabelle C., additional, Lam, Carolyn S.P., additional, Artola, Vicente A., additional, Lang, Chim C., additional, Ng, Leon L., additional, Metra, Marco, additional, Anker, Stefan, additional, Filippatos, Gerasimos, additional, Dickstein, Kenneth, additional, Ponikowski, Piotr, additional, van der Harst, Pim, additional, van der Meer, Peter, additional, van Veldhuisen, Dirk J., additional, Benjamin, Emelia J., additional, Voors, Adriaan A., additional, Samani, Nilesh J., additional, and Rienstra, Michiel, additional

Published
2020
Full Text
View/download PDF

5. Pulmonary vein anatomy addressed by computed tomography and relation to success of second‐generation cryoballoon ablation in paroxysmal atrial fibrillation

Author

Mulder, Bart A., primary, Al‐Jazairi, Meelad I. H., additional, Arends, Bauke K. O., additional, Bax, Niels, additional, Dijkshoorn, Leonard A., additional, Sheikh, Uzaifa, additional, Tan, Eng S., additional, Wiesfeld, Ans C. P., additional, Tieleman, Robert G., additional, Vliegenthart, Rozemarijn, additional, Rienstra, Michiel, additional, van Gelder, Isabelle C., additional, and Blaauw, Yuri, additional

Published
2019
Full Text
View/download PDF

6. Strain imaging to predict response to cardiac resynchronization therapy: a systematic comparison of strain parameters using multiple imaging techniques

Author

Zweerink, Alwin, primary, van Everdingen, Wouter M., additional, Nijveldt, Robin, additional, Salden, Odette A.E., additional, Meine, Mathias, additional, Maass, Alexander H., additional, Vernooy, Kevin, additional, de Lange, Frederik J., additional, Vos, Marc A., additional, Croisille, Pierre, additional, Clarysse, Patrick, additional, Geelhoed, Bastiaan, additional, Rienstra, Michiel, additional, van Gelder, Isabelle C., additional, van Rossum, Albert C., additional, Cramer, Maarten J., additional, and Allaart, Cornelis P., additional

Published
2018
Full Text
View/download PDF

27. Lenient vs. strict rate control in patients with atrial fibrillation and heart failure: a post-hoc analysis of the RACE II study.

Author

Mulder BA, Van Veldhuisen DJ, Crijns HJ, Tijssen JG, Hillege HL, Alings M, Rienstra M, Groenveld HF, Van den Berg MP, and Van Gelder IC

Subjects
Aged, Anti-Arrhythmia Agents pharmacology, Atrial Fibrillation complications, Atrial Fibrillation mortality, Depression, Chemical, Female, Heart Failure complications, Heart Failure mortality, Hospitalization statistics & numerical data, Humans, Male, Middle Aged, Patient Care Planning statistics & numerical data, Quality of Life, Stroke Volume, Treatment Outcome, Anti-Arrhythmia Agents therapeutic use, Atrial Fibrillation drug therapy, Heart Failure drug therapy, Heart Rate drug effects
Abstract

Aims: It is unknown whether lenient rate control is an acceptable strategy in patients with AF and heart failure. We evaluated differences in outcome in patients with AF and heart failure treated with lenient or strict rate control., Methods and Results: This post-hoc analysis of the RACE II trial included patients with an LVEF ≤ 40% at baseline or a previous hospitalization for heart failure or signs and symptoms of heart failure. Primary outcome was a composite of cardiovascular morbidity and mortality. Secondary endpoints were AF-related symptoms and quality of life. Two hundred and eighty-seven (46.7%) of the 614 patients had heart failure. Patients with heart failure had significantly higher NT-proBNP plasma levels, a lower LVEF, and more often used ACE inhibitors, ARBs, and diuretics. At 3 years follow-up, the primary outcome occurred more frequently in patients with heart failure (16.7% vs. 11.5%, P = 0.04). In heart failure patients, the estimated cumulative incidence of the primary outcome was 15.0% (n = 20) in the lenient and 18.2% (n = 26) in the strict group (P = 0.53). No differences were found in any of the primary outcome components, in either heart failure hospitalizations [8 (6.1%) vs. 9 (6.8%) patients in the lenient vs. strict group, respectively], symptoms, or quality of life., Conclusion: In patients with AF and heart failure with a predominantly preserved EF, the stringency of rate control seems to have no effect on cardiovascular morbidity and mortality, symptoms, and quality of life.

Published
2013
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results